StocksDeepDive
Snapshot · Russell 3000 · generated 2026-10-15 21:34 UTC

MRNA — Moderna, Inc.

EXPENSIVE (MOS Model unreliable) · Quality 21/100

Price
236.5
Intrinsic value
21.98
Margin of safety
Model unreliable
Implied growth (reverse DCF)
+56.8%
model assumes +10.0%
Value Score
-18.9
Quality
21
Psychology
-132
Discovery
29.1
price/volume attention only
Moat score
20.2
erosion: watch

Value Score: bottom 1% of Russell 3000 · Quality: bottom 2%

Open the interactive Deep Dive for MRNA →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/MRNA - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is MRNA undervalued?

As of 2026-10-15, MRNA trades at 236.5 against a computed intrinsic value of 21.98 (-975.8% margin of safety) - StocksDeepDive's valuation label for this is EXPENSIVE. This is a described calculation from public data, not a recommendation.

What is Moderna, Inc.'s Value Score?

Moderna, Inc.'s Value Score is -18.9 as of 2026-10-15 - it combines value, quality, crowd psychology and market attention into one number.